No safe harbors for recurrent posterior fossa group A ependymoma: A time for change in risk assignment?

Neuro Oncol. 2023 Oct 3;25(10):1868-1870. doi: 10.1093/neuonc/noad129.

Jordan R Hansford^{1

2

3}, David D Eisenstat^{4

5

6}

¹ Michael Rice Cancer Centre, Women's and Children's Hospital, North Adelaide, South Australia, Australia.
² Precision Cancer Medicine, South Australia Health and Medical Research Institute, Adelaide, South Australia, Australia.
³ South Australia Immunogenomics Cancer Institute, University of Adelaide, Adelaide, South Australia, Australia.
⁴ Children's Cancer Centre, Royal Children's Hospital, Parkville, Victoria, Australia.
⁵ Stem Cell Biology, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
⁶ Department of Paediatrics, University of Melbourne, Parkville, Victoria, Australia.

No abstract available

Publication types